Literature DB >> 5754504

Hemagglutination by rabies virus.

E Kuwert, T J Wiktor, F Sokol, H Koprowski.   

Abstract

Goose erythrocytes were agglutinated by five strains of rabies virus grown in monolayer cell cultures at pH 6.4 and at 0 to 4 C. Hemagglutination was not affected by the cell type in which the virus was grown. Prerequisites for occurrence of hemagglutination are absence of hemagglutination inhibitors (such as those contained in bovine serum) and a relatively high virus concentration (> 10(6) plaque-forming units of virus per ml). "Soluble" hemagglutinin was not present in crude preparations of extracellular virus. Treatment of purified preparations of extracellular virus with Tween 80 and ether did not result in release of a "soluble" hemagglutinin. The hemagglutinating property of extracellular virus seemed to be conditioned by the integrity of its coat. Preparations of infectious intracellular virus exhibited about 15 times lower hemagglutinating activity than extracellular virus. This decreased hemagglutinating activity did not seem to be caused by binding of hemagglutination inhibitors to the virus particles. Rabies virus can be quantitatively adsorbed onto and eluted from erythrocytes. Erythrocytes pretreated with rabies virus retained their ability to be agglutinated by the same virus strain. The reaction with rabies virus of erythrocytes treated with the receptor-destroying enzyme or KIO(4) was the same as that of nontreated erythrocytes. The hemagglutinating component of rabies virus, therefore, does not exhibit neuraminidase activity. Treatment of extracellular virus by various agents indicated that the hemagglutinating component consists of protein or lipoprotein. Sulfhydryl groups present in the viral hemagglutinin are essential for hemagglutination.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5754504      PMCID: PMC375483     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  ANTI-RABIES VACCINE OF TISSUE CULTURE ORIGIN.

Authors:  R E KISSLING; D R REESE
Journal:  J Immunol       Date:  1963-09       Impact factor: 5.422

2.  Routine HA and HAI tests for identifying enterovirus and reovirus strains.

Authors:  P M FEORINO; D D HUMPHREY; H M GELFAND
Journal:  Public Health Rep       Date:  1963-04       Impact factor: 2.792

3.  Hemagglutination by measles virus. III. Identification of two different hemagglutinins.

Authors:  E NORRBY
Journal:  Virology       Date:  1963-02       Impact factor: 3.616

4.  Hemagglutination and hemagglutination-inhibition with Coxsackie B viruses.

Authors:  L ROSEN; J KERN
Journal:  Proc Soc Exp Biol Med       Date:  1961-07

5.  Noninfectious forms of Newcastle disease and influenza viruses; studies on noninfectious virus occurring within cells that are producing fully infectious virus.

Authors:  A GRANOFF
Journal:  Virology       Date:  1955-12       Impact factor: 3.616

6.  Structure of the influenza virus; the relation between biological activity and chemical structure of virus fractions.

Authors:  L HOYLE
Journal:  J Hyg (Lond)       Date:  1952-06

7.  Growth of rubella virus in BHK21 cells. 3. Production of complement-fixing antigens.

Authors:  T Furukawa; A Vaheri; S A Plotkin
Journal:  Proc Soc Exp Biol Med       Date:  1967 Aug-Sep

8.  The tween-ether treated hemagglutinin of parainfluenza 2 virus.

Authors:  T John; P Askin; V A Fulginiti
Journal:  Arch Gesamte Virusforsch       Date:  1967

9.  Morphology of the nucleoprotein component of rabies virus.

Authors:  K Hummeler; N Tomassini; F Sokol; E Kuwert; H Koprowski
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

10.  Rubella hemagglutinin prepared with alkaline extraction of virus grown in suspension culture of BHK-21 cells.

Authors:  P E Halonen; J M Ryan; J A Stewart
Journal:  Proc Soc Exp Biol Med       Date:  1967-05
View more
  21 in total

1.  Reversible conformational changes and fusion activity of rabies virus glycoprotein.

Authors:  Y Gaudin; C Tuffereau; D Segretain; M Knossow; A Flamand
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

2.  Quantitative studies on adsorption, elution, and haemagglutination of vesicular stomatitis virus.

Authors:  P Arstila
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

3.  Hemagglutination by equine infectious anemia virus.

Authors:  H Sentsui; Y Kono
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

4.  Phosphate acceptor amino acid residues in structural proteins of rhabdoviruses.

Authors:  F Sokol; K B Tan; M L McFalls; P Madore
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

5.  Rhabdovirus replication in enucleated host cells.

Authors:  T J Wiktor; H Koprowski
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

6.  Titration and neutralization of rabies virus (ERA strain) following its replication in a pig fallopian tube cell line.

Authors:  A M Bouillant; H Tabel; A S Greig
Journal:  Can J Comp Med       Date:  1974-04

7.  Isolation of a hemagglutinating, immunizing, and non-infectious subunit of the rabies virion.

Authors:  L G Schneider; M Horzinek; R Novický
Journal:  Arch Gesamte Virusforsch       Date:  1971

8.  Recovery of protective activity in rabies virus vaccines concentrated and purified by four different methods.

Authors:  H G Aaslestad; T J Wiktor
Journal:  Appl Microbiol       Date:  1972-07

9.  Demonstration of non-infectious hemagglutinating particles of rabies virus and isolation of the hemagglutinin by disruption of the virion with Nonidet P-40.

Authors:  Y T Arai; A Kondo; K Suzuki
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

10.  Use of the hemadsorption phenomenon for determining virus and neutralizing antibody titers of rabies.

Authors:  N Minamoto; K Kurata; I Kaizuka; H Sazawa
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.